Pharmacists asked to assist in switching patients from Promixin by end of April 2025

A national patient safety alert advises that Colicym 1-million-unit power for nebuliser solution unit dose vials should be considered as an alternative treatment.
A woman breathes through a nebuliser
The national patient safety alert said that as stocks of Colomycin are in short supply, this treatment should be reserved for existing patients and those who require the treatment intravenously

Shutterstock.com

Patients taking Promixin must be switched to an alternative by 30 April 2025, the Department of Health and Social Care (DHSC) and NHS England have said.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated